Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Burger

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Arthritis Research|November 1, 2000
Mesenchymal precursor cells in the blood of normal individualsN J Zvaifler, L Marinova-Mutafchieva, G Adams, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2001
Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cellsA A Horner, G F Widhopf, J A Burger, et al.
Leukemia|November 20, 2015
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemiaS-S Chen, B Y Chang, S Chang, et al.
Leukemia|March 31, 2012
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemiaM Sivina, E Hartmann, E Vasyutina, et al.
Leukemia|February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.
Leukemia|April 29, 2015
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLLK Balakrishnan, M Peluso, M Fu, et al.
Leukemia|January 8, 2010
Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cellsJ A Burger, N S Velev, E J Jabbour, et al.
Leukemia|August 21, 2015
Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndromeF P Tambaro, G Garcia-Manero, S M O'Brien, et al.
Leukemia|October 4, 2017
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.
Leukemia|February 6, 2016
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibitionS Köhrer, O Havranek, F Seyfried, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Arthritis Research|November 1, 2000
Mesenchymal precursor cells in the blood of normal individualsN J Zvaifler, L Marinova-Mutafchieva, G Adams, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2001
Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cellsA A Horner, G F Widhopf, J A Burger, et al.
Leukemia|November 20, 2015
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemiaS-S Chen, B Y Chang, S Chang, et al.
Leukemia|March 31, 2012
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemiaM Sivina, E Hartmann, E Vasyutina, et al.
Leukemia|February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.
Leukemia|April 29, 2015
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLLK Balakrishnan, M Peluso, M Fu, et al.
Leukemia|January 8, 2010
Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cellsJ A Burger, N S Velev, E J Jabbour, et al.
Leukemia|August 21, 2015
Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndromeF P Tambaro, G Garcia-Manero, S M O'Brien, et al.
Leukemia|October 4, 2017
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.
Leukemia|February 6, 2016
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibitionS Köhrer, O Havranek, F Seyfried, et al.
Pageof 4